CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 310 filers reported holding CRISPR THERAPEUTICS AG in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $398,700 | -5.3% | 7,500 | 0.0% | 0.26% | -28.7% |
Q2 2023 | $421,050 | +24.1% | 7,500 | 0.0% | 0.36% | +16.0% |
Q1 2023 | $339,225 | +111487.2% | 7,500 | 0.0% | 0.31% | +6.1% |
Q4 2022 | $304 | -99.9% | 7,500 | 0.0% | 0.29% | -40.2% |
Q3 2022 | $490,000 | +7.7% | 7,500 | 0.0% | 0.49% | +18.6% |
Q2 2022 | $455,000 | -3.2% | 7,500 | 0.0% | 0.42% | +41.2% |
Q1 2022 | $470,000 | -17.3% | 7,500 | 0.0% | 0.29% | -0.3% |
Q4 2021 | $568,000 | -43.6% | 7,500 | -34.8% | 0.30% | -37.9% |
Q3 2021 | $1,007,000 | -41.1% | 11,500 | -8.0% | 0.48% | -41.9% |
Q2 2021 | $1,709,000 | +3.7% | 12,500 | 0.0% | 0.82% | -1.8% |
Q1 2021 | $1,648,000 | -17.2% | 12,500 | -3.8% | 0.83% | -31.7% |
Q4 2020 | $1,990,000 | +83.1% | 13,000 | 0.0% | 1.22% | +59.1% |
Q3 2020 | $1,087,000 | -35.0% | 13,000 | -25.9% | 0.77% | -8.5% |
Q2 2020 | $1,673,000 | +96.6% | 17,551 | 0.0% | 0.84% | +68.8% |
Q1 2020 | $851,000 | -18.6% | 17,551 | +0.2% | 0.50% | -1.8% |
Q4 2019 | $1,045,000 | +45.3% | 17,516 | -0.1% | 0.50% | +31.5% |
Q3 2019 | $719,000 | -16.9% | 17,542 | -0.2% | 0.38% | -10.5% |
Q2 2019 | $865,000 | +36.9% | 17,572 | +0.9% | 0.43% | +41.1% |
Q1 2019 | $632,000 | – | 17,421 | – | 0.30% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |